RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 74 filers reported holding RUBIUS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $566,897 | +129.5% | 103,484 | +309.7% | 0.00% | – |
| Q4 2021 | $247,000 | -44.6% | 25,259 | +1.1% | 0.00% | – |
| Q3 2021 | $446,000 | -31.1% | 24,972 | -5.7% | 0.00% | -100.0% |
| Q2 2021 | $647,000 | +11.7% | 26,488 | +21.2% | 0.00% | 0.0% |
| Q1 2021 | $579,000 | +204.7% | 21,860 | -12.6% | 0.00% | – |
| Q4 2020 | $190,000 | +58.3% | 25,021 | +4.0% | 0.00% | – |
| Q3 2020 | $120,000 | -21.1% | 24,048 | 0.0% | 0.00% | – |
| Q2 2020 | $152,000 | +38.2% | 24,048 | -2.6% | 0.00% | – |
| Q1 2020 | $110,000 | -49.8% | 24,702 | +6.9% | 0.00% | – |
| Q4 2019 | $219,000 | +15.3% | 23,097 | -3.0% | 0.00% | – |
| Q3 2019 | $190,000 | -47.7% | 23,812 | +3.2% | 0.00% | – |
| Q2 2019 | $363,000 | +48.8% | 23,078 | +70.9% | 0.00% | – |
| Q1 2019 | $244,000 | – | 13,505 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 2,618,351 | $11,652,000 | 19.67% |
| Flagship Pioneering Inc. | 38,296,526 | $170,419,000 | 7.99% |
| HARBOURVEST PARTNERS LLC | 986,878 | $4,392,000 | 2.12% |
| Abbot Financial Management, Inc. | 563,500 | $2,508,000 | 2.04% |
| Artal Group S.A. | 3,883,791 | $17,283,000 | 0.73% |
| ARK Investment Management | 318,121 | $1,416,000 | 0.04% |
| Walleye Capital LLC | 34,000 | $151,000 | 0.03% |
| Tekla Capital Management LLC | 155,982 | $694,000 | 0.03% |
| Baillie Gifford | 4,256,900 | $18,943,000 | 0.02% |
| FEDERATED HERMES, INC. | 600,000 | $2,670,000 | 0.01% |